Advertisement
Australia markets closed
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • AUD/USD

    0.6421
    -0.0004 (-0.07%)
     
  • OIL

    83.24
    +0.51 (+0.62%)
     
  • GOLD

    2,406.70
    +8.70 (+0.36%)
     
  • Bitcoin AUD

    99,417.88
    +6,371.55 (+6.85%)
     
  • CMC Crypto 200

    1,371.97
    +59.34 (+4.52%)
     
  • AUD/EUR

    0.6023
    -0.0008 (-0.13%)
     
  • AUD/NZD

    1.0893
    +0.0018 (+0.17%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,037.65
    -356.67 (-2.05%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • Dow Jones

    37,986.40
    +211.02 (+0.56%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

Intuitive Surgical Earnings, Revenue Beat in Q1

Intuitive Surgical Earnings, Revenue Beat in Q1
Intuitive Surgical Earnings, Revenue Beat in Q1

Investing.com - Intuitive Surgical on Thursday reported first-quarter earnings that beat analysts' forecasts and revenue that topped expectations.

Intuitive Surgical (NASDAQ:ISRG) rose 0.50% in after-hours trade.

Intuitive Surgical announced earnings per share of $2.69 on revenue of $1.10 billion. Analysts polled by Investing.com anticipated EPS of $2.68 on revenue of $1.06 billion. That with comparison to EPS of $2.61 on revenue of $973.7 million in the same period a year before. Intuitive Surgical had reported EPS of $3.48 on revenue of $1.28 billion in the previous quarter.

Higher first-quarter revenue was driven by increased procedures and systems placements as well as higher service and operating lease revenue, the company said.

ADVERTISEMENT

Instruments and accessories revenue increased by 12% and systems revenue increased by 14% to $283 million.

"For the first two and a half months of the first quarter of 2020, procedure performance was trending at the higher end of our expectations. However, as noted in the company's April 8 press release, the company experienced a significant decline in procedure volume and postponements of system placements in the latter half of March in the U.S. and Western Europe, as healthcare systems in those areas diverted resources to meet the increasing demands of managing COVID-19," Intuitive Surgical said.

Analysts were expecting the company guided EPS of $2.26 and revenue of $1.01 billion in the upcoming quarter, but the company decided against offering guidance due to a lack of visibility caused by the Covid-19 pandemic.

"Due to the uncertain scope and duration of the pandemic, and uncertain timing of global recovery and economic normalization, we cannot, at this time, reliably estimate the future impact on our operations and financial results," Intuitive Surgical added.

Intuitive Surgical shares are down 13% from the beginning of the year, still down 17.65% from its 52 week high of $619.00 set on February 20. They are outperforming the S&P 500 which is down 13.71% year to date.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Related Articles

Stocks - Dow Cuts Losses as Traders Eye Trump Update on Reopening Economy

L'Oreal eyes post-confinement rush to hair salons

Your Money: Why you might be afraid to spend your stimulus check